Australia’s CSL has announced plans to expand its US presence over the next five years, resulting in approximately $1.5 ...

Swiss generics and biosimilars company Sandoz has announced the launch of Tyruko (natalizumab-sztn) in the USA.

Spanish plasma-based medicines producer Grifols today announced that the US Food and Drug Administration (FDA) has approved ...

South Korean biosimilars developer Celltrion today announced that the European Commission (EC) has granted marketing ...

Canadian firm Zymeworks, a biotech managing a portfolio of licensed healthcare assets while developing a diverse pipeline of ...

South Korean clinical-stage biotech ABL Bio has entered license, research and collaboration agreement with US pharma major ...

New government funding will help make the boldest ideas in UK life sciences a reality – from putting robots to work in ...

A major British initiative is set to repurpose used nuclear materials, converting them into a consistent supply for ...

The US Food and Drug Administration today announced it has approved Danish biotech firm Genmab’s Epkinly (epcoritamab-bysp) ...

Roche today announced positive Phase III results from the lidERA Breast Cancer study evaluating investigational giredestrant ...

Shares of US clinical-stage biopharmaceutical company Nuvalent jumped more than 15% to $111.22 by midday yesterday, after it ...

A clinical‑stage biotech company headquartered in Antwerp, Belgium, developing organ‑restricted therapies for fibrotic ...